HealthEquity Q2 revenue rises 9% to $325.8 million; net income up 67%
HealthEquity reported results for the quarter ended July 31, 2025, with revenue of $325.8 million, up 9% from a year earlier, and GAAP net income of $59.9 million, or $0.68 per diluted share, up from $0.40. The company also set fiscal 2026 outlook calling for revenue of $1.290 billion to $1.310 billion and GAAP net income per diluted share of $2.11 to $2.28.
Key points
- Q2 revenue was $325.8 million, up 9% from $299.9 million; adjusted EBITDA was $151.1 million, up 18%.
- GAAP net income was $59.9 million, or $0.68 per diluted share, versus $35.8 million, or $0.40, a year earlier.
- For the fiscal year ending January 31, 2026, the company expects revenue of $1.290 billion to $1.310 billion and adjusted EBITDA of $540 million to $560 million.
- The company repurchased 0.7 million shares for $66.0 million in the quarter, with $351.8 million remaining authorized as of July 31, 2025.
The filing
Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 02, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.